Variant report

Variant	nsv904182
Chromosome Location	chr15:45146708-45267670
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:632)
CpG islands
(count:366)
Chromatin interactive
region (count:2)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:632 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr15:45181194-45181211	K562	blood:	n/a	n/a
2	ARID3A	chr15:45205265-45205621	HepG2	liver:	n/a	n/a
3	ATF1	chr15:45182020-45182040	K562	blood:	n/a	n/a
4	ATF1	chr15:45168202-45168273	K562	blood:	n/a	n/a
5	ATF2	chr15:45174666-45175297	GM12878	blood:	n/a	n/a
6	ATF2	chr15:45203414-45203775	GM12878	blood:	n/a	n/a
7	ATF2	chr15:45174555-45175594	GM12878	blood:	n/a	n/a
8	ATF2	chr15:45203385-45203780	GM12878	blood:	n/a	n/a
9	BATF	chr15:45204924-45205158	GM12878	blood:	n/a	chr15:45204943-45204952
10	BATF	chr15:45175615-45176106	GM12878	blood:	n/a	n/a
11	BATF	chr15:45214951-45215126	GM12878	blood:	n/a	n/a
12	BATF	chr15:45191947-45192347	GM12878	blood:	n/a	n/a
13	BATF	chr15:45174500-45176189	GM12878	blood:	n/a	n/a
14	BATF	chr15:45203408-45203799	GM12878	blood:	n/a	chr15:45203595-45203606 chr15:45203708-45203717
15	BATF	chr15:45203489-45203757	GM12878	blood:	n/a	chr15:45203595-45203606 chr15:45203708-45203717
16	BATF	chr15:45174732-45175340	GM12878	blood:	n/a	n/a
17	BATF	chr15:45260122-45260297	GM12878	blood:	n/a	n/a
18	BATF	chr15:45191999-45192251	GM12878	blood:	n/a	n/a
19	BCL11A	chr15:45191932-45192270	GM12878	blood:	n/a	n/a
20	BCL11A	chr15:45175417-45176211	GM12878	blood:	n/a	n/a
21	BCL11A	chr15:45174655-45175245	GM12878	blood:	n/a	n/a
22	BCL11A	chr15:45175527-45176004	GM12878	blood:	n/a	n/a
23	BCL11A	chr15:45174637-45175348	GM12878	blood:	n/a	n/a
24	BCL11A	chr15:45203459-45203776	GM12878	blood:	n/a	chr15:45203595-45203604 chr15:45203594-45203603
25	BCL3	chr15:45174662-45175296	GM12878	blood:	n/a	n/a
26	BCLAF1	chr15:45174481-45175331	GM12878	blood:	n/a	n/a
27	BCLAF1	chr15:45174315-45175214	GM12878	blood:	n/a	n/a
28	BCLAF1	chr15:45173453-45173866	GM12878	blood:	n/a	n/a
29	BHLHE40	chr15:45205254-45205588	HepG2	liver:	n/a	n/a
30	BHLHE40	chr15:45175681-45176068	GM12878	blood:	n/a	n/a
31	BHLHE40	chr15:45174566-45175326	GM12878	blood:	n/a	n/a
32	BRCA1	chr15:45197020-45197149	Hela-S3	cervix:	n/a	n/a
33	CBX3	chr15:45153846-45154522	K562	blood:	n/a	n/a
34	CBX3	chr15:45154120-45154506	K562	blood:	n/a	n/a
35	CBX3	chr15:45170134-45170405	K562	blood:	n/a	n/a
36	CBX3	chr15:45149196-45149676	K562	blood:	n/a	n/a
37	CBX3	chr15:45170132-45170460	K562	blood:	n/a	n/a
38	CBX3	chr15:45149305-45149733	K562	blood:	n/a	n/a
39	CBX3	chr15:45248617-45248975	K562	blood:	n/a	n/a
40	CEBPB	chr15:45190198-45190318	A549	lung:	n/a	n/a
41	CEBPB	chr15:45173553-45176123	GM12878	blood:	n/a	n/a
42	CEBPB	chr15:45205257-45205548	HepG2	liver:	n/a	n/a
43	CEBPB	chr15:45190228-45190235	IMR90	lung:	n/a	n/a
44	CEBPB	chr15:45196986-45197328	Hela-S3	cervix:	n/a	n/a
45	CEBPB	chr15:45190110-45190355	K562	blood:	n/a	n/a
46	CEBPB	chr15:45205208-45205573	HepG2	liver:	n/a	n/a
47	CEBPB	chr15:45149277-45149716	K562	blood:	n/a	n/a
48	CEBPB	chr15:45205176-45205593	HepG2	liver:	n/a	n/a
49	CEBPB	chr15:45190116-45190255	HepG2	liver:	n/a	n/a
50	CEBPB	chr15:45174806-45175090	GM12878	blood:	n/a	n/a

(count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr15:45248744-45248794	SK-N-MC	brain:	n/a
2	chr15:45248744-45248794	IMR90	lung:	fetal
3	chr15:45248806-45248856	HNPCEpiC	eye:	n/a
4	chr15:45248463-45248513	AG04449	skin:	fetal
5	chr15:45248463-45248513	SKMC	muscle:	n/a
6	chr15:45248932-45248982	LNCaP	prostate:	n/a
7	chr15:45248806-45248856	Hepatocyte	liver:	n/a
8	chr15:45248878-45248928	AG09319	gingival:	n/a
9	chr15:45247870-45247920	NB4	blood:	n/a
10	chr15:45248878-45248928	K562	blood:	n/a
11	chr15:45248463-45248513	AG09319	gingival:	n/a
12	chr15:45248878-45248928	SK-N-SH_RA	brain:	n/a
13	chr15:45248806-45248856	HMEC	breast:	n/a
14	chr15:45248463-45248513	LNCaP	prostate:	n/a
15	chr15:45248878-45248928	GM12878	blood:	n/a
16	chr15:45248806-45248856	SKMC	muscle:	n/a
17	chr15:45248463-45248513	BE2_C	brain:	n/a
18	chr15:45247870-45247920	AG04449	skin:	fetal
19	chr15:45248932-45248982	BE2_C	brain:	n/a
20	chr15:45248744-45248794	Hela-S3	cervix:	n/a
21	chr15:45247870-45247920	A549	lung:	n/a
22	chr15:45247870-45247920	HepG2	liver:	n/a
23	chr15:45248878-45248928	AoSMC	blood vessel:	n/a
24	chr15:45248744-45248794	AG09309	skin:	n/a
25	chr15:45248463-45248513	U87	brain:	n/a
26	chr15:45248806-45248856	NB4	blood:	n/a
27	chr15:45248744-45248794	AG04450	lung:	fetal
28	chr15:45248932-45248982	GM12891	blood:	n/a
29	chr15:45248806-45248856	K562	blood:	n/a
30	chr15:45248744-45248794	HIPEpiC	eye:	n/a
31	chr15:45248463-45248513	Jurkat	blood:	n/a
32	chr15:45247870-45247920	HEEpiC	esophagus:	n/a
33	chr15:45248744-45248794	SKMC	muscle:	n/a
34	chr15:45248463-45248513	AG09309	skin:	n/a
35	chr15:45248744-45248794	MCF10A-Er-Src	breast:	n/a
36	chr15:45248463-45248513	HCPEpiC	choroid plexus:	n/a
37	chr15:45247870-45247920	HNPCEpiC	eye:	n/a
38	chr15:45248806-45248856	RPTEC	kidney:	n/a
39	chr15:45248932-45248982	AG09319	gingival:	n/a
40	chr15:45247870-45247920	NT2-D1	testis:	n/a
41	chr15:45247870-45247920	HCPEpiC	choroid plexus:	n/a
42	chr15:45248878-45248928	GM12892	blood:	n/a
43	chr15:45248463-45248513	HRE	kidney:	n/a
44	chr15:45248878-45248928	IMR90	lung:	fetal
45	chr15:45248463-45248513	PANC-1	pancreas:	n/a
46	chr15:45248932-45248982	AG10803	skin:	n/a
47	chr15:45248744-45248794	HAEpiC	amniotic membrane:	n/a
48	chr15:45248744-45248794	HepG2	liver:	n/a
49	chr15:45248878-45248928	PrEC	prostate:	n/a
50	chr15:45248932-45248982	HMEC	breast:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr15:45003163..45005190-chr15:45225441..45227864,2	K562	blood:
2	chr15:45153661..45154310-chr15:45315073..45315837,2	NB4	blood:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DUOX2-4	chr15:45262233-45263376	NONHSAT042205
2	lnc-C15orf43-2	chr15:45174295-45174981	NONHSAT042199
3	lnc-C15orf43-1	chr15:45212156-45213018	NONHSAT042202
4	lnc-C15orf43-1	chr15:45211574-45211851	NONHSAT042202

No data

Variant related genes	Relation type
ENSG00000259479	TF binding region
RNU6-966P	TF binding region
C15orf43	TF binding region
RNU6-1332P	TF binding region
RNU1-119P	TF binding region
ENSG00000259742	TF binding region
ENSG00000259304	TF binding region
RNU6-1108P	TF binding region
ENSG00000259231	TF binding region
ENSG00000259479	CpG island
RNU6-966P	CpG island
C15orf43	CpG island
RNU6-1332P	CpG island
RNU1-119P	CpG island
ENSG00000259742	CpG island
ENSG00000259304	CpG island
RNU6-1108P	CpG island
ENSG00000259231	CpG island
ENSG00000166710	chromatin interactions
ENSG00000140263	chromatin interactions
ENSG00000229474	chromatin interactions

Extended variants
information (count: 1901 )
Associated
traits (count: 68 )

Variant overlapped rSNPs/rCNVs (count:1901 , 50 per page) page: 1 2 3 4 5 6 7 ... 39

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs16975956	chr15:45146708-45146709	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs369088236	chr15:45146722-45146723	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs550849595	chr15:45146732-45146733	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs190964490	chr15:45146739-45146740	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs144710540	chr15:45146750-45146751	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs553963751	chr15:45146816-45146817	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs572292246	chr15:45146821-45146822	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs1720679	chr15:45146862-45146863	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs182395305	chr15:45146870-45146871	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs562057241	chr15:45146881-45146882	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs35235716	chr15:45146882-45146883	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs1720680	chr15:45146910-45146911	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs551565793	chr15:45146922-45146923	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs571459578	chr15:45146949-45146950	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs561246053	chr15:45146964-45146965	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs376915429	chr15:45146970-45146971	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs148836643	chr15:45146977-45146978	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs557271256	chr15:45146994-45146995	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs377543717	chr15:45147001-45147002	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs201940582	chr15:45147035-45147036	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs200017420	chr15:45147080-45147081	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs553066300	chr15:45147108-45147109	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs564695940	chr15:45147156-45147157	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs573303666	chr15:45147158-45147159	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs545133326	chr15:45147167-45147168	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs532247780	chr15:45147195-45147196	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs558789746	chr15:45147205-45147206	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs547159878	chr15:45147274-45147275	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs565908633	chr15:45147329-45147330	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs200978198	chr15:45147333-45147334	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs201622797	chr15:45147348-45147349	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs139770254	chr15:45147368-45147369	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs149367037	chr15:45147378-45147379	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs559852327	chr15:45147446-45147447	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs532235748	chr15:45147496-45147497	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs551898411	chr15:45147591-45147592	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs548544409	chr15:45147672-45147673	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs202000688	chr15:45147678-45147679	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs568601986	chr15:45147686-45147687	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs200243279	chr15:45148057-45148058	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs187880879	chr15:45148058-45148059	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs550740987	chr15:45148065-45148066	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs192658896	chr15:45148375-45148376	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs184927470	chr15:45148392-45148393	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs553343239	chr15:45148465-45148466	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs373008150	chr15:45148602-45148603	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs566708249	chr15:45148618-45148619	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs111686693	chr15:45148624-45148625	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs79429879	chr15:45148648-45148649	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs142402627	chr15:45148662-45148663	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:68)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Schizophrenia	19415332	CNVD
Breast cancer	22522925	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Testicular germ cell tumor	18059402	CNVD
cataract	16735990	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Medulloblastoma	21979893	CNVD
spastic paraplegia with thinning of corpus callosum	19105190	CNVD
Schizophrenia	21324950	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Disease	21824424	CNVD
Melanoma	18172304	CNVD
Colorectal cancer	16774939	CNVD
Gastric cancer	17167181	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Colorectal cancer	16272173	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Multiple myeloma	17550852	CNVD
Intellectual disability	22102821	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Prostate cancer	16573809	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Multiple myeloma	20724749	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	21785460	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Ovarian cancer	22174824	CNVD
Prostate cancer	18632612	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Basal cell lymphoma	17053054	CNVD
Cancer	21129771	CNVD
Papillary thyroid carcinoma	22161024	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	21045282	CNVD
Breast cancer	22032731	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Abnormal phenotypes	18644119	CNVD
Cancer	16751803	CNVD
Melanoma	17363583	CNVD
Acute myeloid leukemia	19651601	CNVD
Marfan syndrome	17492313	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Non-syndromic sensorineural hearing loss	19212409	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Renal cell carcinoma	21215367	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:92 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:45144400-45147200	Enhancers	Liver	Liver
2	chr15:45145600-45147200	Enhancers	Primary neutrophils fromperipheralblood	blood
3	chr15:45146000-45147000	Enhancers	Primary monocytes fromperipheralblood	blood
4	chr15:45146000-45153200	Weak transcription	K562	blood
5	chr15:45146200-45147200	Enhancers	Monocytes-CD14+_RO01746	blood
6	chr15:45146200-45147600	Enhancers	HepG2	liver
7	chr15:45147200-45148400	Weak transcription	Liver	Liver
8	chr15:45147600-45151200	Weak transcription	HepG2	liver
9	chr15:45148400-45149000	Enhancers	Liver	Liver
10	chr15:45149000-45151200	Weak transcription	Liver	Liver
11	chr15:45151200-45151600	Enhancers	Liver	Liver
12	chr15:45151600-45152800	Weak transcription	Liver	Liver
13	chr15:45152800-45154000	Enhancers	Liver	Liver
14	chr15:45153200-45153800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
15	chr15:45153200-45154400	Enhancers	K562	blood
16	chr15:45153800-45154000	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
17	chr15:45153800-45154400	ZNF genes & repeats	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
18	chr15:45154400-45155200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
19	chr15:45155200-45155400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
20	chr15:45158000-45158600	Enhancers	HepG2	liver
21	chr15:45167800-45172600	ZNF genes & repeats	GM12878-XiMat	blood
22	chr15:45172600-45172800	Weak transcription	GM12878-XiMat	blood
23	chr15:45172800-45174400	Active TSS	GM12878-XiMat	blood
24	chr15:45173600-45177200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
25	chr15:45174200-45176000	Enhancers	HMEC	breast
26	chr15:45174400-45174600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
27	chr15:45174400-45175000	Enhancers	H1 Cell Line	embryonic stem cell
28	chr15:45174400-45175000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
29	chr15:45174400-45175000	Flanking Active TSS	GM12878-XiMat	blood
30	chr15:45174400-45175400	Enhancers	NHEK	skin
31	chr15:45174400-45175800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
32	chr15:45174600-45175000	Enhancers	HUES48 Cell Line	embryonic stem cell
33	chr15:45174600-45175000	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
34	chr15:45174600-45175000	Bivalent Enhancer	HepG2	liver
35	chr15:45174600-45175400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
36	chr15:45174600-45176000	Enhancers	Breast Myoepithelial Primary Cells	Breast
37	chr15:45174800-45177800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
38	chr15:45175000-45175400	Active TSS	GM12878-XiMat	blood
39	chr15:45175000-45176000	Enhancers	HepG2	liver
40	chr15:45175000-45176200	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
41	chr15:45175400-45176400	Enhancers	Primary T regulatory cells fromperipheralblood	blood
42	chr15:45175400-45176400	Flanking Active TSS	GM12878-XiMat	blood
43	chr15:45175800-45185200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
44	chr15:45176400-45177000	Enhancers	GM12878-XiMat	blood
45	chr15:45180200-45182000	Enhancers	K562	blood
46	chr15:45187800-45188800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
47	chr15:45187800-45189000	Enhancers	Primary T helper naive cells from peripheral blood	blood
48	chr15:45187800-45189000	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
49	chr15:45188000-45189400	Enhancers	Primary T regulatory cells fromperipheralblood	blood
50	chr15:45188200-45188600	Enhancers	Primary T cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links